Pharmaceuticals

Pharmacy Giant Walgreens Taps Tim Wentworth to Be CEO

The incoming chief executive faces a tough challenge, with a core business under pressure due to pharmacy-benefit managers such as…

9 months ago

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion

The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link

9 months ago

The Company That Defined Dieting Is Sorry It Told Us to Have More Willpower

Ozempic, Oprah and apologies: WeightWatchers says there’s no shame in being overweight, or in taking new weight-loss drugs. Source link

9 months ago

The World Needs New Antibiotics, but the Business Model Is Broken

New drugs to defeat “superbug” bacteria aren’t reaching patients. Source link

9 months ago

J&J's $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion

The healthcare giant’s separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining…

10 months ago

To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts

Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link

10 months ago

Amgen's Deal for Horizon Therapeutics Clears Key Hurdle

The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact…

10 months ago

FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics

The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source…

10 months ago

Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges

The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link

11 months ago

Ozempic Settles the Obesity Debate: It's Biology Over Willpower

Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link

11 months ago